Australian biotechnology company CSL Limited has grown into one of the world’s leading healthcare firms, supplying life-saving medicines and vaccines to millions of people across the globe.

Founded in Melbourne in 1916 as the Commonwealth Serum Laboratories, CSL has expanded into a global biotechnology leader with operations in more than 100 countries.

The company specialises in plasma therapies, influenza vaccines, and treatments for rare and serious diseases through its businesses, CSL Behring, CSL Seqirus, and CSL Vifor.

CSL invests billions of dollars in research and development each year, helping advance medical innovation while supporting thousands of jobs worldwide.

Today, CSL is recognised as one of Australia’s most valuable companies and remains a major contributor to the country’s biotechnology industry and global healthcare sector.